Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2018 and Recent Developments

Go back to Avid Bioservices Reports Financial Results for Quarter and Fiscal Year Ended April 30, 2018 and Recent Developments

Avid Bioservices (CDMO) Tops Q4 EPS by 12c

July 16, 2018 4:29 PM EDT

Avid Bioservices (NASDAQ: CDMO) reported Q4 EPS of ($0.03), $0.12 better than the analyst estimate of ($0.15). Revenue for the quarter came in at $6.94 million versus the consensus estimate of $6.14 million.

For earnings history and earnings-related data on Avid Bioservices (CDMO) click here.

... More